NCT03434795View on ClinicalTrials.gov

Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy

CompletedOBSERVATIONAL
Enrollment

1,900

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Febrile Neutropenia, Rule of Clinical Decision, Chemotherapy
Trial Locations (1)

Unknown

Hôpital Jeanne de Flandre - CHRU de Lille, Lille

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

collaborator

Ligue contre le cancer, France

OTHER

lead

University Hospital, Lille

OTHER

NCT03434795 - Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy | Biotech Hunter | Biotech Hunter